Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David W. Eisele is active.

Publication


Featured researches published by David W. Eisele.


Laryngoscope | 1992

Caustic ingestion injuries of the upper aerodigestive tract

John C. Scott; Bronwyn Jones; David W. Eisele; William J. Ravich

Few reports have described in detail the injuries that occur to the oral cavity, pharynx, and larynx following caustic ingestion.1 The role of dynamic radiographic studies to delineate the extent of damage has been minimized.2 In‐depth radiographic analysis of such cases has not, to our knowledge, been previously reported. In order to examine the injuries and functional abnormalities of these sites following caustic ingestion, the records of The Johns Hopkins Swallowing Center were reviewed. Five patients were identified as having significant upper aerodigestive tract caustic injuries. All patients had dysphagia, epiglottis injuries, and incomplete laryngeal protection with aspiration. Four of five had sustained some degree of esophageal stenosis. Also noted were pharyngeal muscle dysfunction, nasopharyngeal regurgitation, tongue fixation, and hypopharyngeal stenosis. Roentgenographic findings are described and illustrated. The multidisciplinary approach to the management and rehabilitation of these patients is discussed.


Clinical Cancer Research | 2004

Salivary Transcriptome Diagnostics for Oral Cancer Detection

Yang Li; Maie A. St. John; Xiaofeng Zhou; Yong Kim; Uttam K. Sinha; Richard Jordan; David W. Eisele; Elliot Abemayor; David Elashoff; No-Hee Park; David T. Wong

Purpose: Oral fluid (saliva) meets the demand for noninvasive, accessible, and highly efficient diagnostic medium. Recent discovery that a large panel of human RNA can be reliably detected in saliva gives rise to a novel clinical approach, salivary transcriptome diagnostics. The purpose of this study is to evaluate the diagnostic value of this new approach by using oral squamous cell carcinoma (OSCC) as the proof-of-principle disease. Experimental Design: Unstimulated saliva was collected from patients (n = 32) with primary T1/T2 OSCC and normal subjects (n = 32) with matched age, gender, and smoking history. RNA isolation was done from the saliva supernatant, followed by two-round linear amplification with T7 RNA polymerase. Human Genome U133A microarrays were applied for profiling human salivary transcriptome. The different gene expression patterns were analyzed by combining a t test comparison and a fold-change analysis on 10 matched cancer patients and controls. Quantitative polymerase chain reaction (qPCR) was used to validate the selected genes that showed significant difference (P < 0.01) by microarray. The predictive power of these salivary mRNA biomarkers was analyzed by receiver operating characteristic curve and classification models. Results: Microarray analysis showed there are 1,679 genes exhibited significantly different expression level in saliva between cancer patients and controls (P < 0.05). Seven cancer-related mRNA biomarkers that exhibited at least a 3.5-fold elevation in OSCC saliva (P < 0.01) were consistently validated by qPCR on saliva samples from OSCC patients (n = 32) and controls (n = 32). These potential salivary RNA biomarkers are transcripts of IL8, IL1B, DUSP1, HA3, OAZ1, S100P, and SAT. The combinations of these biomarkers yielded sensitivity (91%) and specificity (91%) in distinguishing OSCC from the controls. Conclusions: The utility of salivary transcriptome diagnostics is successfully demonstrated in this study for oral cancer detection. This novel clinical approach could be exploited to a robust, high-throughput, and reproducible tool for early cancer detection. Salivary transcriptome profiling can be applied to evaluate its usefulness for other major disease applications as well as for normal health surveillance.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2013

Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region.

Hisham M. Mehanna; Tom Beech; Tom Nicholson; Iman El-Hariry; Christopher C. McConkey; Vinidh Paleri; Sally Roberts; David W. Eisele

Little information has been reported on regional and time trends of human papillomavirus (HPV) prevalence rates of oropharyngeal cancer (OPC) and non‐OPC.


Journal of The National Comprehensive Cancer Network | 2011

Head and Neck Cancers

Arlene A. Forastiere; K. Kian Ang; David M. Brizel; Bruce Brockstein; Barbara Burtness; Anthony J. Cmelak; Alexander D. Colevas; Frank R. Dunphy; David W. Eisele; Helmuth Goepfert; Wesley L. Hicks; Merrill S. Kies; William M. Lydiatt; Ellie Maghami; Renato Martins; Thomas V. McCaffrey; Bharat B. Mittal; David G. Pfister; Harlan A. Pinto; Marshall R. Posner; John A. Ridge; Sandeep Samant; David E. Schuller; Jatin P. Shah; S.A. Spencer; Andy Trotti; Randal S. Weber; Gregory T. Wolf; F. Worden

Recent evidence suggests that dysregulated translation and its control significantly contribute to the etiology and pathogenesis of the head and neck cancers, specifically to that of squamous cell carcinoma (HNSCC). eIF4E is one of the most studied components of the translation machinery implicated in the development and progression of HNSCC. It appears that dysregulation of eIF4E levels and activity, namely by the PI3K/AKT/mTOR pathway, plays an important role in the etiology and pathogenesis of HNSCC and correlates with clinical outcomes. In this chapter, we will discuss the role of eIF4E and some other translation factors as they relate to the biology and treatment of HNSCC.


Journal of The National Comprehensive Cancer Network | 2015

Head and neck cancers, version 1.2015 featured updates to the NCCN guidelines

David G. Pfister; S.A. Spencer; David M. Brizel; Barbara Burtness; Paul M. Busse; Jimmy J. Caudell; Anthony J. Cmelak; A. Dimitrios Colevas; Frank R. Dunphy; David W. Eisele; Robert L. Foote; Jill Gilbert; Maura L. Gillison; Robert I. Haddad; Bruce H. Haughey; Wesley L. Hicks; Ying J. Hitchcock; Antonio Jimeno; Merrill S. Kies; William M. Lydiatt; Ellie Maghami; Thomas V. McCaffrey; Loren K. Mell; Bharat B. Mittal; Harlan A. Pinto; John A. Ridge; Cristina P. Rodriguez; Sandeep Samant; Jatin P. Shah; Randal S. Weber

These NCCN Guidelines Insights focus on nutrition and supportive care for patients with head and neck cancers. This topic was a recent addition to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers. The NCCN Guidelines Insights focus on major updates to the NCCN Guidelines and discuss the new updates in greater detail. The complete version of the NCCN Guidelines for Head and Neck Cancers is available on the NCCN Web site (NCCN.org).


Laryngoscope | 1996

Intraoperative Electrophysiologic Monitoring of the Recurrent Laryngeal Nerve

David W. Eisele

Intraoperative electrophysiologic monitoring of the recurrent laryngeal nerve was performed with a commercially available device consisting of an endotracheal tube with integrated stainless‐steel‐wire surface EMG electrodes positioned at the level of the true vocal cords. Forty‐two recurrent laryngeal nerves were successfully monitored with this system in 31 patients undergoing thyroidectomy or parathyroidectomy. In all cases, evoked EMG responses were elicited by direct electrical recurrent laryngeal nerve stimulation. Stimulus thresholds for evoked responses ranged from 0.2 to 0.6 mA (mean 0.3 mA) for the 37 nerves with preoperative ipsilateral normal vocal cord mobility. Mechanically evoked potentials with acoustic signals were also detected during the surgical procedures related to recurrent laryngeal nerve manipulation. It may be concluded that surface electrode monitoring of the recurrent laryngeal nerve with this system provides a simplified, noninvasive technique that is as sensitive as monitoring with intramuscular laryngeal electrodes.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2000

Esthesioneuroblastoma: the Johns Hopkins experience.

Vicente A. Resto; David W. Eisele; Arlene A. Forastiere; Marianna Zahurak; Ding Jen Lee; William H. Westra

Esthesioneuroblastoma (ENB) is an uncommon malignant neoplasm of the upper nasal cavity. Therapeutic management approaches for this neoplasm lack uniformity and there is no universally accepted staging system.


Oral Oncology | 2014

The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas

Eleni M. Benson; Ryan Li; David W. Eisele; Carole Fakhry

Human papillomavirus (HPV) is etiologically responsible for a distinct subset of head and neck squamous cell cancers (HNSCCs). HPV-positive HNSCCs (HPV-HNSCCs) most commonly arise from the oropharynx and are responsible for the increasing incidence of oropharyngeal SCC (OSCC) in the United States (US) and abroad. HPV-positive OSCC (HPV-OSCC) has a unique demographic and risk factor profile and tumor biology. HPV-OSCC patients tend to be white, younger, and have a higher cumulative exposure to sexual behaviors as compared with HPV-negative OSCC patients. HPV-positive tumor status also significantly improves survival, and is indeed the single strongest prognostic factor for OSCC. The mechanisms that underlie the improved prognosis conferred by HPV-positive disease are unknown. The purpose of this review is to describe the clinical impact of HPV status in HNSCC, particularly in OSCC, both in terms of the unique clinic-demographic profile and prognostic implications.


Cancer | 2008

Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience.

Kim Huang; P. Xia; Cynthia H. Chuang; Vivian Weinberg; Christine M. Glastonbury; David W. Eisele; Nancy Y. Lee; Sue S. Yom; Theodore L. Phillips; Jeanne M. Quivey

Treatment outcomes for stage III and IV oropharyngeal carcinoma treated with intensity‐modulated radiotherapy (IMRT) and concurrent chemotherapy without prior surgical resection were reviewed.


Otolaryngology-Head and Neck Surgery | 2001

Oncologic Rationale for Bilateral Tonsillectomy in Head and Neck Squamous Cell Carcinoma of Unknown Primary Source

Wayne M. Koch; Nassir Bhatti; Mark F. Williams; David W. Eisele

OBJECTIVE: To demonstrate an oncologic basis for the recommendation to perform bilateral tonsillectomy as a routine measure in the search for a primary mucosal lesion in patients presenting with cervical nodal metastasis of squamous cell carcinoma (SCC). STUDY DESIGN: A case series of individuals selected from a 3-year period is reported. SETTING: Academic medical center. RESULTS: Each individual presented with metastatic squamous cell carcinoma in a cervical lymph node from an unknown primary source. In each case, the primary source was identified in a tonsillectomy specimen, either located contralateral to the node, or in both tonsils. CONCLUSIONS: The rate of contralateral spread of metastatic cancer from occult tonsil lesions appears to approach 10%. For this reason, bilateral tonsillectomy is recommended as a routine step in the search for the occult primary in patients presenting with cervical metastasis of SCC and palatine tonsils intact.

Collaboration


Dive into the David W. Eisele's collaboration.

Top Co-Authors

Avatar

Carole Fakhry

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar

Wayne M. Koch

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Harry Quon

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar

Steven J. Wang

University of California

View shared research outputs
Top Co-Authors

Avatar

Alan R. Schwartz

Belfast Health and Social Care Trust

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Osamu Tetsu

University of California

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge